Login to Your Account

Cadherin the great

Targeting cadherin-11 in rheumatoid arthritis could provide a complement to existing therapies, Adheron Therapeutics Inc. CEO Hari Kumar told BioWorld Today, and "that's exactly how we pitched it" to Roche AG.more »

Our Habitat for All Things Science
Vaccines are bright spot in infectious disease fight

SAN DIEGO – Predictions at the International Conference on Antimicrobials and Chemotherapy and the International Congress of Chemotherapy (ICAAC/ICC) 2015 annual meeting tend to be of the dire sort, warning of a return to the pre-penicillin era. So it was a pleasant exception to listen to Glaxosmithkline plc's Rino Rappuoli brim with optimism during his plenary talk on challenges and opportunities of vaccines.



Partners in Focus